The main purpose of this legislation, known as the Shandra Eisenga Human Cell and Tissue Product Safety Act, is to enhance public and healthcare provider awareness about the risks and benefits associated with human cell and tissue product transplants. It aims to ensure that both the public and professionals in the healthcare field are well-informed about these products, which can include organs, tissues, and cellular-based therapies.